Louisiana Medicaid might add coverage for popular obesity treatment drugs

By: Julie O'Donoghue

Outlets: Louisiana Illuminator

Published: April 16, 2026

Words: 642

Last Updated: 3 months, 2 weeks ago

Body Text Preview

Louisiana’s Medicaid program could expand access to popular weight-loss medications such as Wegovy and Zepbound for obesity treatment starting in January.

The state Senate Health and Welfare Committee moved forward Wednesday with Senate Bill 433, which would allow adults with a body mass index of 35 to 39 to access what are known as GLP-1 drugs for obesity if they have another chronic condition, or comorbidity, including prediabetes, hypertension or cardiovascular disease.

The bill’s …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

FAQ

Email Us